Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Recher

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Cell Cycle (Georgetown, Tex.)|April 21, 2010
A functional link between polo-like kinase 1 and the mammalian target-of-rapamycin pathway?Annelies G Renner, Laurent Créancier, Cédric Dos Santos, et al.
Dermatology (Basel, Switzerland)|October 1, 2015
Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the LiteratureMarie Masson Regnault, Noémie Gadaud, Serge Boulinguez, et al.
Leukemia & Lymphoma|June 22, 2013
Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemiaCaroline Le Jeune, Sarah Bertoli, Mohamed Elhamri, et al.
Leukemia Research|October 9, 2009
Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome statusMariette Matondo, Marie-Pierre Bousquet-Dubouch, Nathalie Gallay, et al.
Leukemia & Lymphoma|December 3, 2016
Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemiaNorbert Vey, Thomas Prebet, Claire Thalamas, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 8, 2018
FLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid LeukemiaMarielle Perry, Sarah Bertoli, Clément Rocher, et al.
Cancers|December 24, 2021
SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-KinaseYoucef Ounoughene, Elise Fourgous, Yvan Boublik, et al.
Ejhaem|July 18, 2022
A case of cup-like blasts associated with B-lymphoblastic leukemia without <i>NPM1</i> and <i>FLT3</i> internal tandem duplication mutationsJean-Baptiste Rieu, Lucie Coster, Jill Corre, et al.
The European Respiratory Journal|July 11, 2015
Blood stem cell transplantation to treat cystic lung light chain deposition diseaseAurélie Le Borgne, Grégoire Prévot, Isabelle Rouquette, et al.
Blood|April 2, 2011
Is active acid sphingomyelinase required for the antiproliferative response to rituximab?Frédérique Sabourdy, Janick Selves, Leonardo Astudillo, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Cell Cycle (Georgetown, Tex.)|April 21, 2010
A functional link between polo-like kinase 1 and the mammalian target-of-rapamycin pathway?Annelies G Renner, Laurent Créancier, Cédric Dos Santos, et al.
Dermatology (Basel, Switzerland)|October 1, 2015
Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the LiteratureMarie Masson Regnault, Noémie Gadaud, Serge Boulinguez, et al.
Leukemia & Lymphoma|June 22, 2013
Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemiaCaroline Le Jeune, Sarah Bertoli, Mohamed Elhamri, et al.
Leukemia Research|October 9, 2009
Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome statusMariette Matondo, Marie-Pierre Bousquet-Dubouch, Nathalie Gallay, et al.
Leukemia & Lymphoma|December 3, 2016
Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemiaNorbert Vey, Thomas Prebet, Claire Thalamas, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 8, 2018
FLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid LeukemiaMarielle Perry, Sarah Bertoli, Clément Rocher, et al.
Cancers|December 24, 2021
SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-KinaseYoucef Ounoughene, Elise Fourgous, Yvan Boublik, et al.
Ejhaem|July 18, 2022
A case of cup-like blasts associated with B-lymphoblastic leukemia without <i>NPM1</i> and <i>FLT3</i> internal tandem duplication mutationsJean-Baptiste Rieu, Lucie Coster, Jill Corre, et al.
The European Respiratory Journal|July 11, 2015
Blood stem cell transplantation to treat cystic lung light chain deposition diseaseAurélie Le Borgne, Grégoire Prévot, Isabelle Rouquette, et al.
Blood|April 2, 2011
Is active acid sphingomyelinase required for the antiproliferative response to rituximab?Frédérique Sabourdy, Janick Selves, Leonardo Astudillo, et al.
Pageof 14